Track topics on Twitter Track topics that are important to you
The primary objective is to compare the efficacy and safety of extended release tramadol HCl/acetaminophen with placebo for the treatment of chronic low-back pain by measuring the pain intensity difference between baseline and week 4.
This is a randomized (study drug assigned by chance), double-blind (neither physician nor patient knows the name of the assigned drug), placebo-controlled, parallel group and up-titration study. At screening, patients taking non-steroidal anti-inflammatory drugs (NSAIDS) or COX-2 selective inhibitors (NSAID that specifically inhibits an enzyme known as cyclooxygenase-2) for the treatment of severe chronic lower back pain will be instructed to continue this treatment through the 7 day screening period, at which point their suitability for on-going participation in the study is determined by comparing their baseline average pain intensity to that of the last 48 hours. Patients will be randomized to receive either study drug Tramadol HCl/acetaminophen Extended Release or its equivalent placebo. Patients will take 1 tablet of Tramadol HCl/acetaminophen Extended Release at bedtime for 3 days, then 1 tablet twice a day for 3 days. After the first 3 days, the patient will receive a telephone inquiry monitoring for the occurrence of adverse events and will be given additional administration instructions for the next 4 days. From day 7, patients will take 1 or 2 tablets twice a day depending on the degree of pain relief required. Patients will visit the center on the 8, 15, and 29 day (Visit 3, 4, and 5) after starting study drug. On visits 3 - 5 or if the patient discontinues from the study for any reason, the investigator will evaluate the average pain intensity level and the pain relief experienced over the past 48 hours. When the double-blind part the study is complete, the KOREAN SF-36 and K-ODI (questionnaires patients are asked to complete that are used as tools to evaluate health outcomes) will be evaluated. On the last visit, the overall effectiveness of the study drug in controlling chronic lower back pain and all adverse events after the administration of the study drug will be reviewed. 1 tablet of tramadol HCl/acetaminophen at bedtime for 3 days, then 1 tablet twice a day for 3 days. Starting at day 7, patients will take 1 or 2 tablets twice a day depending on their need for pain relief. After completing the screening period, each patient will be randomized to receive either the study drug (or its equivalent placebo) until study completion, day 29
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Low Back Pain
Tramadol HCl/acetaminophen Extended Release, Tramadol HCl/acetaminophen Extended Release, Placebo, Placebo
Janssen Korea, Ltd., Korea
Published on BioPortfolio: 2014-07-24T14:05:56-0400
A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers
The objectives of this two-part study were to compare the single-dose and multiple-dose pharmacokinetics of extended release and immediate-release fixed combination formulations containing...
The objective of this observational study is to assess improvement of quality of life in the patients who are administered Tramadol 37.5mg/Acetaminophen 325mg tablets for 10~14 weeks accor...
The purpose of this study is to explore the pain-relieving effects and safety of Tramadol HCl/acetaminophen as compared to placebo in patients experiencing acute low back pain. Tramadol HC...
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of Extended Release Hydrocodone/Acetaminophen and Immediate Release Hydr...
The purpose of this study is to compare the effectiveness of acetaminophen extended release caplets to placebo in treating the muscle aching and pain (soreness) that occurs after a maratho...
Damage to the liver can lead to changes in the metabolism of tramadol. In this study, the rate of tramadol metabolites in rats with damaged liver induced by ethanol and acetaminophen were assessed in ...
Drug combination for the treatment of pain is common clinical practice. Co-crystal of Tramadol-Celecoxib (CTC) consists of two active pharmaceutical ingredients (APIs), namely the atypical opioid tram...
Acetaminophen is one of the most commonly used analgesic and antipyretic drugs. It has been reported that acetaminophen has anticonvulsant effects in several animal models of seizure. An active metabo...
Tramadol overdose is disproportionately more common in Iran, and in recent years, it has become one of the most common causes of poisoning admissions to emergency departments in this country. Tramadol...
Tramadol, a centrally acting analgesic drug, has relatively high affinity to serotonin transporter (5-HTT) and norepinephrine transporter (NET) in addition to μ-opioid receptor. Based on this charact...
A narcotic analgesic proposed for severe pain. It may be habituating.
Hydrophilic contact lenses worn for an extended period or permanently.
Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage.
A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...